Literature DB >> 6176457

Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets.

R S Accolla, R P Sekaly, A P McDonald, G Corte, N Gross, S Carrel.   

Abstract

The expression at the cell surface level of two previously defined human Ia antigen subsets, NG1 and NG2, was studied. Two monoclonal hybridoma antibodies, D1-12 (anti-NG1) and D4-22 (anti-NG2), labeled with distinct fluorochromes, were used as probes. The results indicate that NG1 and NG2 molecules are simultaneously expressed on the same cell, and moreover, that they are identifiable as spatially separate structures. In addition, when a series of 6 other anti-Ia monoclonal antibodies previously described were analyzed in a checkerboard test of binding inhibition at the cell surface level, they were found to closely mimic the reactivity pattern of either D1-12 or D4-22 antibody, suggesting that NG1 and NG2 Ia subsets express independent clusters of highly immunogenic epitopes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176457     DOI: 10.1002/eji.1830120212

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.

Authors:  J Michon; Y Henin; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production.

Authors:  A S Mustafa; G Kvalheim; M Degre; T Godal
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

3.  Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.

Authors:  D Zeliszewski; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.

Authors:  F Vánky; G Stuber; S Rotstein; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Characterization of N-linked oligosaccharides of an HLA-DR molecule expressed in different cell lines.

Authors:  D Néel; B Merlu; E Turpin; C Rabourdin-Combe; B Mach; Y Goussault; D J Charron
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

6.  Structure and expression of HLA-DQ alpha and -DX alpha genes: interallelic alternate splicing of the HLA-DQ alpha gene and functional splicing of the HLA-DQ alpha gene using a retroviral vector.

Authors:  C Auffray; J W Lillie; A J Korman; J M Boss; N Fréchin; F Guillemot; J Cooper; R C Mulligan; J L Strominger
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  An antiviral T-cell clone defines a functional supertypic specificity shared by different HLA-DR molecules from DR2-short, DRw11, and DRw13 haplotypes.

Authors:  D Zeliszewski; G Sterkers; J Choppin; C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens.

Authors:  M Colombatti; C Bron
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

9.  Isolation of distinct cDNA clones encoding HLA-DR beta chains by use of an expression assay.

Authors:  E O Long; C T Wake; M Strubin; N Gross; R S Accolla; S Carrel; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy.

Authors:  N Rizzuto; T Cavallaro; S Monaco; M Morbin; B Bonetti; S Ferrari; S Galiazzo-Rizzuto; G Zanette; L Bertolasi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.